{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T21:41:21Z","timestamp":1788298881942,"version":"build-2803163510"},"reference-count":23,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,12,4]],"date-time":"2025-12-04T00:00:00Z","timestamp":1764806400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2025,12,4]],"date-time":"2025-12-04T00:00:00Z","timestamp":1764806400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100006260","name":"Technion - Israel Institute of Technology","doi-asserted-by":"crossref","id":[{"id":"10.13039\/501100006260","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Support Care Cancer"],"published-print":{"date-parts":[[2026,1]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Introduction<\/jats:title>\n                    <jats:p>Dietary and herbal supplements (DHS) are used by 30% of hematological patients despite safety concerns. A service of integrative safety consultations was implemented in the Hematological Institute of Bnai Zion Medical Center. This study examines the effect of such consultation on DHS safety in hematologic patients.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>Patients from the Hematological Institute were referred to the \u201cintegrative safety consultation team.\u201d The naturopath recommended DHS according to symptoms disclosed, and safety analysis was performed by the clinical pharmacist. Symptom and side effect assessment was repeated in each follow-up visit to evaluate DHS safety.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>\n                      Between 2021 and 2024, 42 patients were included. Twenty-eight (67%) used DHS before the consultation. Employed patients were more likely to use DHS (\n                      <jats:italic>p<\/jats:italic>\n                      \u2009=\u20090.02). A total of 176 potential interactions were described in 30 patients. Most interactions were theoretical (45%), with a pharmacodynamic additive mechanism (59%), involving herbs (82%) and antihypertensives (26%) or anticoagulants (23%). One side effect was disclosed following\n                      <jats:italic>Hericium<\/jats:italic>\n                      prescription to a patient that developed leg edema and neuropathic pain exacerbation (probable causality according to the Naranjo scale and FDA algorithm). Patients\u2019 concerns improved from the first to the second visit. In 21% of the patients who used DHS before the consultation, DHS was documented in the medical chart by the time of first consultation, all of them pertaining to vitamins or minerals.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>Consideration of DHS in the management of patients with hematological conditions requires a systematic and comprehensive process to ensure patient safety and wellbeing. An integrative safety naturopathic-pharmacologic consultation can address such needs.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1007\/s00520-025-10227-z","type":"journal-article","created":{"date-parts":[[2025,12,4]],"date-time":"2025-12-04T07:48:33Z","timestamp":1764834513000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["Implementation of an integrative safety consultation service for the use of dietary and herbal supplements among patients with hematological diseases"],"prefix":"10.1007","volume":"34","author":[{"given":"Ilana","family":"Levy Yurkovski","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sohair","family":"Bishara-Swaid","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ohad","family":"Cohen-Naznin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yael","family":"Gross-Geva","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tamar","family":"Elyakim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Samuel","family":"Attias","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elad","family":"Schiff","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tamar","family":"Tadmor","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,12,4]]},"reference":[{"issue":"1","key":"10227_CR1","doi-asserted-by":"publisher","first-page":"5","DOI":"10.1016\/S0738-3991(03)00241-6","volume":"53","author":"SM Giveon","year":"2004","unstructured":"Giveon SM, Liberman N, Klang S, Kahan E (2004) Are people who use \u201cnatural drugs\u201d aware of their potentially harmful side effects and reporting to family physician? Patient Educ Couns 53(1):5\u201311","journal-title":"Patient Educ Couns"},{"key":"10227_CR2","doi-asserted-by":"crossref","unstructured":"Wu C-H, Wang C-C, Kennedy J (2011) Changes in herb and dietary supplement use in the U.S. adult population: a comparison of the 2002 and 2007 National Health Interview Surveys. Clin Ther 33(11):1749\u201358","DOI":"10.1016\/j.clinthera.2011.09.024"},{"issue":"8","key":"10227_CR3","doi-asserted-by":"publisher","first-page":"1414","DOI":"10.3109\/10428194.2010.487622","volume":"51","author":"E Ben-Arye","year":"2010","unstructured":"Ben-Arye E, Attias S, Tadmor T, Schiff E (2010) Herbs in hemato-oncological care: an evidence-based review of data on efficacy, safety, and drug interactions. Leuk Lymphoma 51(8):1414\u20131423","journal-title":"Leuk Lymphoma"},{"issue":"12","key":"10227_CR4","doi-asserted-by":"publisher","first-page":"1966","DOI":"10.1016\/j.jada.2006.09.002","volume":"106","author":"BB Timbo","year":"2006","unstructured":"Timbo BB, Ross MP, Mccarthy PV, Lin CTJ (2006) Dietary supplements in a national survey: prevalence of use and reports of adverse events. J Am Diet Assoc 106(12):1966\u20131974","journal-title":"J Am Diet Assoc"},{"issue":"11","key":"10227_CR5","doi-asserted-by":"publisher","first-page":"5627","DOI":"10.5958\/0974-360X.2019.00974.0","volume":"12","author":"MJ Alomar","year":"2019","unstructured":"Alomar MJ, Bloukh S, Eid DA (2019) Dietary supplement use, adverse events and related health effects among population of UAE: a cross-sectional study. Res J Pharm Technol 12(11):5627\u20135632","journal-title":"Res J Pharm Technol"},{"issue":"10","key":"10227_CR6","doi-asserted-by":"publisher","first-page":"1851","DOI":"10.1016\/j.jand.2022.01.014","volume":"122","author":"JJ Knapik","year":"2022","unstructured":"Knapik JJ, Trone DW, Steelman RA, Farina EK, Lieberman HR (2022) Adverse effects associated with multiple categories of dietary supplements: the military dietary supplement use study. J Acad Nutr Diet 122(10):1851\u20131863","journal-title":"J Acad Nutr Diet"},{"issue":"3","key":"10227_CR7","doi-asserted-by":"publisher","first-page":"301","DOI":"10.1007\/s11739-016-1548-x","volume":"12","author":"I Levy","year":"2017","unstructured":"Levy I, Attias S, Ben-Arye E, Goldstein L, Schiff E (2017) Potential drug interactions with dietary and herbal supplements during hospitalization. Intern Emerg Med 12(3):301\u2013310","journal-title":"Intern Emerg Med"},{"issue":"4","key":"10227_CR8","doi-asserted-by":"publisher","first-page":"836","DOI":"10.1111\/bcp.13158","volume":"83","author":"I Levy","year":"2017","unstructured":"Levy I, Attias S, Ben-Arye E, Goldstein L, Schiff E (2017) Adverse events associated with interactions with dietary and herbal supplements among inpatients. Br J Clin Pharmacol 83(4):836\u2013845","journal-title":"Br J Clin Pharmacol"},{"issue":"9","key":"10227_CR9","doi-asserted-by":"publisher","first-page":"1679","DOI":"10.1038\/leu.2009.83","volume":"23","author":"G Perrone","year":"2009","unstructured":"Perrone G, Hideshima T, Ikeda H, Okawa Y, Calabrese E, Gorgun G et al (2009) Ascorbic acid inhibits antitumor activity of bortezomib in vivo. Leukemia 23(9):1679\u20131686","journal-title":"Leukemia"},{"key":"10227_CR10","unstructured":"Cupp MJ (1999) Herbal remedies: adverse effects and drug interactions. Am Fam Physician. 59(5):1239\u201345. Accessed 15 Jun 2024"},{"issue":"5","key":"10227_CR11","doi-asserted-by":"publisher","first-page":"777","DOI":"10.1111\/j.1365-2141.2005.05689.x","volume":"130","author":"NA Ramsay","year":"2005","unstructured":"Ramsay NA, Kenny MW, Davies G, Patel JP (2005) Complimentary and alternative medicine use among patients starting warfarin. Br J Haematol 130(5):777\u2013780","journal-title":"Br J Haematol"},{"issue":"21","key":"10227_CR12","doi-asserted-by":"publisher","first-page":"4250","DOI":"10.1182\/blood.V120.21.4250.4250","volume":"120","author":"B Metzke","year":"2012","unstructured":"Metzke B, Hug MJ, Fink G, Hieke S, Jung M, Engelhardt M (2012) Drug-drug interactions in the hematology and oncology department: a real-life assessment of frequency and severity. Blood 120(21):4250\u20134250","journal-title":"Blood"},{"issue":"1","key":"10227_CR13","doi-asserted-by":"publisher","first-page":"339","DOI":"10.1182\/asheducation-2018.1.339","volume":"2018","author":"SR Vazquez","year":"2018","unstructured":"Vazquez SR (2018) Drug-drug interactions in an era of multiple anticoagulants: a focus on clinically relevant drug interactions. Hematol 2018(1):339\u2013347","journal-title":"Hematol"},{"issue":"12","key":"10227_CR14","doi-asserted-by":"publisher","first-page":"1523","DOI":"10.1007\/s11912-023-01476-4","volume":"25","author":"I Levy Yurkovski","year":"2023","unstructured":"Levy Yurkovski I, Andreazzoli F, Ben-Arye E, Attias S, Tadmor T (2023) Integrative approaches in the treatment of patients affected by lymphoma. Curr Oncol Rep 25(12):1523\u20131534","journal-title":"Curr Oncol Rep"},{"key":"10227_CR15","unstructured":"Natural Medicines Comprehensive Database. Available from: https:\/\/naturalmedicines.therapeuticresearch.com\/Home\/ND. Accessed Nov 17, 2025"},{"key":"10227_CR16","unstructured":"Lexicomp drug interactions. Available at: https:\/\/www.uptodate.com\/contents\/search. Accessed Nov 17, 2025"},{"key":"10227_CR17","unstructured":"Memorial Sloan Kettering Cancer Center. About Herbs. Available at: https:\/\/www.mskcc.org\/cancer-care\/diagnosis-treatment\/symptom-management\/integrative-medicine\/herbs. Accessed Nov 17, 2025"},{"issue":"11","key":"10227_CR18","doi-asserted-by":"publisher","first-page":"14","DOI":"10.1136\/bmjopen-2015-009038","volume":"5","author":"K Ide","year":"2015","unstructured":"Ide K, Yamada H, Kitagawa M, Kawasaki Y, Buno Y, Matsushita K et al (2015) Methods for estimating causal relationships of adverse events with dietary supplements. BMJ Open 5(11):14\u201316","journal-title":"BMJ Open"},{"issue":"19","key":"10227_CR19","doi-asserted-by":"publisher","first-page":"4815","DOI":"10.1002\/cncr.27427","volume":"118","author":"RJ Maggiore","year":"2012","unstructured":"Maggiore RJ, Gross CP, Togawa K, Tew WP, Mohile SG, Owusu C et al (2012) Use of complementary medications among older adults with cancer. Cancer 118(19):4815\u20134823","journal-title":"Cancer"},{"issue":"2","key":"10227_CR20","doi-asserted-by":"publisher","first-page":"461","DOI":"10.1007\/s00432-021-03625-3","volume":"148","author":"CPJG Wolf","year":"2022","unstructured":"Wolf CPJG, Rachow T, Ernst T, Hochhaus A, Zomorodbakhsch B, Foller S et al (2022) Interactions in cancer treatment considering cancer therapy, concomitant medications, food, herbal medicine and other supplements. J Cancer Res Clin Oncol 148(2):461\u201373","journal-title":"J Cancer Res Clin Oncol"},{"issue":"9","key":"10227_CR21","doi-asserted-by":"publisher","first-page":"1237","DOI":"10.1007\/s00228-019-02700-6","volume":"75","author":"J Ziemann","year":"2019","unstructured":"Ziemann J, Lendeckel A, M\u00fcller S, Horneber M, Ritter CA (2019) Herb-drug interactions: a novel algorithm-assisted information system for pharmacokinetic drug interactions with herbal supplements in cancer treatment. Eur J Clin Pharmacol 75(9):1237\u20131248","journal-title":"Eur J Clin Pharmacol"},{"issue":"1","key":"10227_CR22","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s40816-015-0002-3","volume":"1","author":"S Suroowan","year":"2015","unstructured":"Suroowan S, Mahomoodally F (2015) Common phyto-remedies used against cardiovascular diseases and their potential to induce adverse events in cardiovascular patients. Clin Phytoscience 1(1):1\u201313","journal-title":"Clin Phytoscience"},{"issue":"1","key":"10227_CR23","doi-asserted-by":"publisher","first-page":"38","DOI":"10.1016\/j.ctim.2006.03.006","volume":"15","author":"C Paterson","year":"2007","unstructured":"Paterson C, Thomas K, Manasse A, Cooke H, Peace G (2007) Measure yourself concerns and wellbeing (MYCaW): an individualised questionnaire for evaluating outcome in cancer support care that includes complementary therapies. Complement Ther Med 15(1):38\u201345","journal-title":"Complement Ther Med"}],"container-title":["Supportive Care in Cancer"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00520-025-10227-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00520-025-10227-z","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00520-025-10227-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,1,21]],"date-time":"2026-01-21T08:46:45Z","timestamp":1768985205000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00520-025-10227-z"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,12,4]]},"references-count":23,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2026,1]]}},"alternative-id":["10227"],"URL":"https:\/\/doi.org\/10.1007\/s00520-025-10227-z","relation":{},"ISSN":["0941-4355","1433-7339"],"issn-type":[{"value":"0941-4355","type":"print"},{"value":"1433-7339","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,12,4]]},"assertion":[{"value":"24 March 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"27 November 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"4 December 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The study was approved by the institutional ethics committee of Bnai Zion Medical Center in accordance with the Declaration of Helsinki (Approval No. 0149\u201320-BNZ) and registered at\n                      \n                      (NCT05982262).","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval statement"}},{"value":"The authors declare no competing interests.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"6"}}